BRAF and thyroid gland undifferentiated (anaplastic) carcinoma: The most common driver mutations for anaplastic thyroid cancer occur in the BRAF or RAS genes, and drugs that target the BRAF kinase have had higher response rates than cytotoxic chemotherapy [20].